Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Prevalence and associated factors for poor mental health among young migrants in Sweden: a cross-sectional studyGlobal health action, 2024-12, Vol.17 (1), p.2294592-2294592 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;ISSN: 1654-9880 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2023.2294592 ;PMID: 38180014Full text available |
|
2 |
Material Type: Article
|
Association between combination COVID-19-influenza vaccination and long COVID in middle-aged and older Europeans: A cross-sectional studyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2345505-2345505 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2345505 ;PMID: 38724010Full text available |
|
3 |
Material Type: Article
|
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide surveyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2334084-2334084 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2334084 ;PMID: 38563792Full text available |
|
4 |
Material Type: Article
|
COVID-19 clinical trial participation and awareness in TexasHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2340692-2340692 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2340692 ;PMID: 38658140Full text available |
|
5 |
Material Type: Article
|
Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survivalCancer biology & therapy, 2024-12, Vol.25 (1), p.2350249-2350249 [Peer Reviewed Journal]ISSN: 1538-4047 ;EISSN: 1555-8576 ;DOI: 10.1080/15384047.2024.2350249 ;PMID: 38722731Full text available |
|
6 |
Material Type: Article
|
Dynamics of SARS-CoV-2 antibodies after natural infection: insights from a study on Pasteur Institute of Tunis employeesLibyan journal of medicine, 2024-12, Vol.19 (1), p.2348233-2348233 [Peer Reviewed Journal]ISSN: 1993-2820 ;EISSN: 1819-6357 ;DOI: 10.1080/19932820.2024.2348233 ;PMID: 38693671Full text available |
|
7 |
Material Type: Article
|
Herpes zoster in older adults: Impact on carbon footprint in the United StatesHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2335722-2335722 [Peer Reviewed Journal]2024 GSK. Published with license by Taylor & Francis Group, LLC. 2024 GSK ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2335722 ;PMID: 38698759Full text available |
|
8 |
Material Type: Article
|
Estimation of cause-specific mortality in Rakai, Uganda, using verbal autopsy 1999-2019Global health action, 2024-12, Vol.17 (1), p.2338635-2338635 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2338635 ;PMID: 38717826Full text available |
|
9 |
Material Type: Article
|
Ultrasound-guided percutaneous thermal ablation of parotid tumors: experience from two-centersInternational journal of hyperthermia, 2024-12, Vol.41 (1), p.2290924 [Peer Reviewed Journal]ISSN: 0265-6736 ;EISSN: 1464-5157 ;DOI: 10.1080/02656736.2023.2290924 ;PMID: 38159559Full text available |
|
10 |
Material Type: Article
|
Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patientsHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2343544-2343544 [Peer Reviewed Journal]2024 GSK. Published with license by Taylor & Francis Group, LLC. 2024 GSK ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2343544 ;PMID: 38655676Full text available |
|
11 |
Material Type: Article
|
The Effectiveness of 23-valent Pneumococcal Polysaccharide Vaccine on Elderly Colorectal Cancer Long-Term Survivors: A population-based exact-matched cohort studyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2350093-2350093 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2350093 ;PMID: 38744302Full text available |
|
12 |
Material Type: Article
|
Impact of the COVID-19 pandemic on social media utilization, influences related to parental vaccine decision making, and opinions on trustworthy social media vaccination campaigns: A qualitative analysisHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2311476-2311476 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2311476 ;PMID: 38356267Full text available |
|
13 |
Material Type: Article
|
Radiographic evaluation of teeth with pulp stones and pulp canal obliteration: characteristics, and associations with dental parametersLibyan journal of medicine, 2024-12, Vol.19 (1), p.2306768-2306768 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1993-2820 ;EISSN: 1819-6357 ;DOI: 10.1080/19932820.2024.2306768 ;PMID: 38258544Full text available |
|
14 |
Material Type: Article
|
Association between friends' hesitancy and personal COVID-19 vaccine hesitancy among Chinese medical staffHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2344290-2344290 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2344290 ;PMID: 38682698Full text available |
|
15 |
Material Type: Article
|
Significant response to pembrolizumab plus lenvatinib in Epstein-Barr-virus-associated intrahepatic cholangiocarcinoma: a case reportCancer biology & therapy, 2024-12, Vol.25 (1), p.2338644-2338644 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 1538-4047 ;EISSN: 1555-8576 ;DOI: 10.1080/15384047.2024.2338644 ;PMID: 38650446Full text available |
|
16 |
Material Type: Article
|
Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in ChinaJournal of medical economics, 2024-12, Vol.27 (1), p.16 [Peer Reviewed Journal]EISSN: 1941-837X ;DOI: 10.1080/13696998.2023.2289297 ;PMID: 38037348Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Knowledge about, attitudes toward and acceptance and predictors of intention to receive the mpox vaccine among cancer patients in China: A cross-sectional surveyHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2337157-2337157 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2337157 ;PMID: 38644633Full text available |
|
18 |
Material Type: Article
|
Care-seeking patterns and timely access to care among survivors of sexual violence in North Kivu, the Democratic Republic of the Congo: a retrospective file-based studyGlobal Health Action, 2024-12, Vol.17 (1), p.2336708-2336708 [Peer Reviewed Journal]ISSN: 1654-9880 ;ISSN: 1654-9716 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2336708 ;PMID: 38660982Full text available |
|
19 |
Material Type: Article
|
Benefits, challenges, and strategies related to using presumptive recommendations for HPV vaccination: A qualitative study with rural and non-rural-serving primary care professionalsHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2347018-2347018 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2347018 ;PMID: 38708779Full text available |
|
20 |
Material Type: Article
|
SPP1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinomaHuman vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2350101-2350101 [Peer Reviewed Journal]2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2350101 ;PMID: 38738709Full text available |